The company’s FDA-approved first generic sertraline capsules secured a 180‑day exclusivity period, highlighting strategic generic development pathways.

Gartner, Inc. IT has reported second-quarter 2025 results, wherein earnings and revenues surpassed the Zacks Consensus ...

Charles River Laboratories on Wednesday raised its annual profit forecast, betting on growing demand for its drug discovery and development services from drugmakers, sending its shares up more than 4% ...

William von Mueffling’s Cantillon Capital grew to $17.34B by smartly balancing high-conviction stocks, trimming gains, and ...

Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia/small ...

Lupin posted a strong Q1 with net profit rising 52% YoY to ₹1,219 crore, surpassing estimates. Robust US sales and improved ...

The pharmacovigilance automation market is gaining strong momentum worldwide, with projections indicating it will generate hundreds of millions in revenue between 2025 and 2034.Ottawa, Aug. 05, 2025 ...

SAN FRANCISCO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Lucidworks, the leading AI-powered search and product discovery provider, today released new B2B-focused findings from its third annual Generative AI ...